Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 2, 2012, Pages 426-430

  Saadeh, Yamaan ^a   Gohil, Kartik ^a   Bill, Charles ^b   Smith, Curtis ^b   Morrison, Chet ^a,b   Mosher, Benjamin ^a,b   Schneider, Paul ^a,b   Stevens, Penny ^b   Kepros, John P ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Claire Dart Stroke Center Sparrow Hospital   (United States)

Author keywords

intracranial hemorrhage; Thromboembolism prophylaxis; traumatic brain injury

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX;

BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG SAFETY; FOLLOW UP; HUMAN; INJURY SEVERITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEUROIMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THERAPY EFFECT; THROMBOSIS PREVENTION; TRAUMATIC BRAIN INJURY; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; BRAIN INJURIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT SAFETY; PRIMARY PREVENTION; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84864574158     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31825a758b     Document Type: Review

References (25)

1. Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost. 2009;102:951Y957.
2. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med. 1998; 158:585Y593.
3. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:I4YI8.
4. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis. 2006;21:23Y29.
5. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Office of the Surgeon General (US); 2008. Available at http://www.surgeongeneral.gov/topics/deepvein
6. Abstracts of the American Society of Hematology 47th annual meeting, December 10Y13, 2005
7. Atlanta, Georgia, USA. Blood. 2005;106: 5aY1030a.
8. Mahan CE, Holdsworth MT, Welch SM, Borrego M, Spyropoulos AC. Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event. Thromb Haemost. 2011;106:405Y415. Epub 2011 Aug 2011.
9. O'Carroll CB, Capampangan DJ, Aguilar MI, Bravo TP, Hoffman- Snyder CR, Wingerchuk DM, Wellik KE, Demaerschalk BM. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic. Neurologist. 2011;17:232Y235.
10. Orken DN, Kenangil G, Ozkurt H, Guner C, Gundogdu L, Basak M, Forta H. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009; 15:329Y331.
11. Kiphuth IC, Staykov D, Köhrmann M, Struffert T, Richter G, Bardutzky J, Kollmar R, Maürer M, Schellinger PD, Hilz MJ, et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis. 2009;27:146Y150. Epub 2008 Nov 2028.
12. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466Y467.
13. Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: A multicenter registry study. Chest. 2011; 140:1436Y1446.
14. Toker S, Hak DJ, Morgan SJ. Deep vein thrombosis prophylaxis in trauma patients. Thrombosis. 2011;2011:505373. Epub 502011 May 505315.
15. Denson K, Morgan D, Cunningham R, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193:380Y383; discussion 383Y384.
16. Ekeh AP, Dominguez KM, Markert RJ, McCarthy MC. Incidence and risk factors for deep venous thrombosis after moderate and severe brain injury. J Trauma. 2010;68:912Y915.
17. Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, Herrmann D, Peppard W. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg. 2011;213:148Y153.
18. Rogers FB, Cipolle MD, et al. Practice management guidelines for the management of venous thromboembolism in trauma patients:The EAST Practice Parameter Workgroup. J Trauma. 1997;5:142Y164.
19. Malinoski D, Ewing T, Patel MS, Jafari F, Sloane B, Nguyen B, Pate C, Kong A, Cinat M, Dolich M, et al. Risk factors for venous thromboembolism in critically ill trauma patients who cannot receive chemical prophylaxis. Injury. November 1, 2011. [ePub ahead of print]
20. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolismin patientswith proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338:409Y415.
21. Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: An AAST multicenter study. J Trauma. 2007;62:17Y24; discussion 24Y15.
22. Helling TS, Kaswan S, Miller SL, Tretter JF. Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: A single-center experience. J Trauma. 2009;67:1293Y1296.
23. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677Y681.
24. Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65:1021Y1026; discussion 1026Y1027.
25. Anderson FA Jr, Goldhaber SZ, Tapson VF, Bergmann JF, Kakkar AK, Deslandes B, Huang W, Cohen AT; ENDORSE Investigators. Improving practices in US hospitals to prevent venous thromboembolism: lessons from ENDORSE. Am J Med. 2010;123:1099Y1106; e1098.